Dian Diagnostics Group Co.,Ltd. (SHE:300244)

Market Cap	9.93B +13.9%
Revenue (ttm)	9.98B -13.9%
Net Income	129.43M
EPS	0.21
Shares Out	611.10M
PE Ratio	76.73
Forward PE	24.33
Dividend	0.35 (2.08%)
Ex-Dividend Date	n/a

Volume	17,534,901
Open	16.51
Previous Close	16.82
Day's Range	15.97 - 17.20
52-Week Range	13.52 - 33.30
Beta	0.71
Analysts	Buy
Price Target	18.84 (+15.94%)
Earnings Date	Aug 21, 2026

About Dian Diagnostics Group

Dian Diagnostics Group Co.,Ltd. provides integrated medical diagnostics solutions with independent diagnostic services in China. The company offers laboratory supplies and kits; AI-assisted digital pathology diagnosis solutions, such as nucleic acid extraction and purification system, automatic liquid-based cytology slide preparation and staining system, digital pathology slide scanner, automated pathology slide staining system, genotyping DNA test kit, human papillomavirus nucleic acid detection kit, PCR system and detection system, and virus ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1996
• Employees: 7,462
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300244

Analyst Summary

According to 8 analysts, the average rating for 300244 stock is "Buy." The 12-month stock price target is ¥18.84, which is an increase of 15.94% from the latest price.

Price Target

¥18.84

(15.94% upside)

Analyst Consensus: Buy